Patent intelligence · US
US 10548905
Amorphous onapristone compositions and methods of making the same
Amorphous onapristone compositions and methods of making the same
Patent details — US 10548905
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 4, 2020
- Expiration
- Jan 30, 2040
- Applicant
- CONTEXT BIOPHARMA, INC.
- Claims
- 7
- CPC classes
- A61K, A61K31/575, A61K9/146, A61K9/1635
Quick answer
US 10548905 (Amorphous onapristone compositions and methods of making the same) is held by CONTEXT BIOPHARMA, INC.. Status: granted. Granted Feb 4, 2020. Expires Jan 30, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CONTEXT BIOPHARMA, INC.
- Grant date
- Expiration
- Claims
- 7
- CPC classes
- A61K, A61K31/575, A61K9/146, A61K9/1635, A61K9/1641, A61K9/1682
More from CONTEXT BIOPHARMA, INC.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 10548905?
US 10548905 (Amorphous onapristone compositions and methods of making the same) is held by CONTEXT BIOPHARMA, INC.. Status: granted. Granted Feb 4, 2020. Expires Jan 30, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10548905?
CONTEXT BIOPHARMA, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 10548905 expire?
Our index shows an expiration date of Jan 30, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.